In the most recent quarter (Q1), Decoy Therapeutics reported EPS of $-4.18, missing estimates of $-4.08 by 0.02%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%. Decoy Therapeutics ...
On Nov 14, 2025, DCOY reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -6.00 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results